Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64(5): 543–52 ArticlePubMed Google Scholar
Manji HK, Zarate CA. Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics. Mol Psychiatry 2002; 7Suppl. 1: S1–7 ArticlePubMedCAS Google Scholar
Zarate Jr CA, Singh J, Manji HK. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 2006; 59(11): 1006–20 ArticlePubMedCAS Google Scholar
Casabona G. Intracellular signal modulation: a pivotal role for protein kinase C. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21(3): 407–25 ArticlePubMedCAS Google Scholar
Tanaka C, Nishizuka Y. The protein kinase C family for neuronal signaling. Annu Rev Neurosci 1994; 17: 551–67 ArticlePubMedCAS Google Scholar
Serova M, Ghoul A, Benhadji KA, et al. Preclinical and clinical development of novel agents that target the protein kinase C family. Semin Oncol 2006; 33(4): 466–78 ArticlePubMedCAS Google Scholar
Toker A. Signaling through protein kinase C. Front Biosci 1998; 3: D1134–47 PubMedCAS Google Scholar
Mellor H, Parker PJ. The extended protein kinase C super-family. Biochem J 1998; 332 (Pt 2): 281–92 PubMedCAS Google Scholar
Takai Y, Kishimoto A, Inoue M, et al. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues I: purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 1977; 252(21): 7603–9 PubMedCAS Google Scholar
Huang KP, Nakabayashi H, Huang FL. Isozymic forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase. Proc Natl Acad Sci U S A 1986; 83(22): 8535–9 ArticlePubMedCAS Google Scholar
Mackay HJ, Twelves CJ. Targeting the protein kinase C family: are we there yet? Natl Rev Cancer 2007; 7(7): 554–62 ArticleCAS Google Scholar
Churchill E, Budas G, Vallentin A, et al. PKC Isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol Toxicol 2008; 48: 569–99 ArticlePubMedCAS Google Scholar
Aksoy E, Goldman M, Willems F. Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol 2004; 36(2): 183–8 ArticlePubMedCAS Google Scholar
Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007; 55(6): 498–510 ArticlePubMed Google Scholar
Calabrese B, Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 2005; 48(1): 77–90 ArticlePubMedCAS Google Scholar
Craske ML, Fivaz M, Batada NN, et al. Spines and neurite branches function as geometric attractors that enhance protein kinase C action. J Cell Biol 2005; 170(7): 1147–58 ArticlePubMedCAS Google Scholar
Hongpaisan J, Alkon DL. A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC. Proc Natl Acad Sci U S A 2007; 104(49): 19571–6 ArticlePubMedCAS Google Scholar
Manji HK, Lenox RH. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999; 46(10): 1328–51 ArticlePubMedCAS Google Scholar
Einat H, Yuan P, Szabo ST, et al. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 2007; 55(3–4): 123–31 ArticlePubMedCAS Google Scholar
Finlay JM, Zigmond MJ, Abercrombie ED. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 1995; 64: 619–28 ArticlePubMedCAS Google Scholar
Birnbaum SG, Yuan PX, Wang M, et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004; 306: 882–4 ArticlePubMedCAS Google Scholar
Runyan JD, Moore AN, Dash PK. A role for prefrontal calcium-sensitive protein phosphatase and kinase activities in working memory. Learn Mem 2005; 12: 103–10 ArticlePubMed Google Scholar
Arnsten AFT, Manji HK. Mania: a rational neurobiology. Future Neurol 2008; 3(2): 125–31 Article Google Scholar
Coyle JT, Duman RS. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003; 38(2): 157–60 ArticlePubMedCAS Google Scholar
Steketee JD. Injection of the protein kinase inhibitor H7 into the A10 dopamine region blocks the acute responses to cocaine: behavioral and in vivo microdialysis studies. Neuropharmacology 1993; 32(12): 1289–97 ArticlePubMedCAS Google Scholar
Chen G, Manji HK, Hawver DB, et al. Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 1994; 63(6): 2361–4 ArticlePubMedCAS Google Scholar
Browman KE, Kantor L, Richardson S, et al. Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res 1998; 814(1–2): 112–9 ArticlePubMedCAS Google Scholar
Kantor L, Gnegy ME. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 1998; 284(2): 592–8 PubMedCAS Google Scholar
Jope RS. Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 1999; 4(2): 117–28 ArticlePubMedCAS Google Scholar
Bitran JA, Potter WZ, Manji HK, et al. Chronic Li+ attenuates agonist- and phorbol ester-mediated Na+/H+ antiporter activity in HL-60 cells. Eur J Pharmacol 1990; 188(4–5): 193–202 PubMedCAS Google Scholar
Giambalvo CT. Protein kinase C and dopamine transport: 2. Effects of amphetamine in vitro. Neuropharmacology 1992; 31(12): 1211–22 ArticlePubMedCAS Google Scholar
Giambalvo CT. Protein kinase C and dopamine transport: 1. Effects of amphetamine in vivo. Neuropharmacology 1992; 31(12): 1201–10 CAS Google Scholar
Friedman E, Hoau-Yan-Wang, Levinson D, et al. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 1993; 33(7): 520–5 ArticlePubMedCAS Google Scholar
Gnegy ME, Hong P, Ferrell ST. Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res Mol Brain Res 1993; 20(4): 289–98 ArticlePubMedCAS Google Scholar
Manji HK, Etcheberrigaray R, Chen G, et al. Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme. J Neurochem 1993; 61(6): 2303–10 ArticlePubMedCAS Google Scholar
Manji HK, Bersudsky Y, Chen G, et al. Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol. Neuropsychopharmacology 1996; 15(4): 370–81 ArticlePubMedCAS Google Scholar
Cervo L, Mukherjee S, Bertaglia A, et al. Protein kinases A and C are involved in the mechanisms underlying consolidation of cocaine place conditioning. Brain Res 1997; 775(1–2): 30–6 ArticlePubMedCAS Google Scholar
Birnbaum SG, Yuan PX, Wang M, et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004; 306(5697): 882–4 ArticlePubMedCAS Google Scholar
Wang HY, Friedman E. Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacology (Berl) 1989; 99(2): 213–8 ArticleCAS Google Scholar
Lenox RH, Watson DG, Patel J, et al. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res 1992; 570(1–2): 333–40 ArticlePubMedCAS Google Scholar
Steketee JD. Intra-A10 injection of H7 blocks the development of sensitization to cocaine. Neuroreport 1994; 6(1): 69–72 ArticlePubMedCAS Google Scholar
Wang HY, Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 1996; 40(7): 568–75 ArticlePubMedCAS Google Scholar
Watson DG, Lenox RH. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J Neurochem 1996; 67(2): 767–77 ArticlePubMedCAS Google Scholar
Wang HY, Markowitz P, Levinson D, et al. Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. J Psychiatr Res 1999; 33(2): 171–9 ArticlePubMedCAS Google Scholar
Hahn CG, Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1999; 1(2): 81–6 ArticlePubMedCAS Google Scholar
Soares JC, Chen G, Dippold CS, et al. Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study. Psychiatry Res 2000; 95(2): 109–18 ArticlePubMedCAS Google Scholar
Wang HY, Johnson GP, Friedman E. Lithium treatment inhibits protein kinase C translocation in rat brain cortex. Psychopharmacology (Berl) 2001; 158(1): 80–6 ArticleCAS Google Scholar
Wang H, Friedman E. Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder. Biol Psychiatry 2001; 50(5): 364–70 ArticlePubMedCAS Google Scholar
Kurita M, Nishino S, Ohtomo K, et al. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(3): 600–4 ArticlePubMedCAS Google Scholar
Pandey GN, Ren X, Dwivedi Y, et al. Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: effect of treatment with mood stabilizing drugs. J Psychiatr Res 2008; 42(2): 106–16 ArticlePubMed Google Scholar
Kulkarni J, Garland KA, Scaffidi A, et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 2006; 31(4): 543–7 ArticlePubMedCAS Google Scholar
Bebchuk JM, Arfken CL, Dolan-Manji S, et al. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000; 57(1): 95–7 ArticlePubMedCAS Google Scholar
Zarate Jr CA, Singh JB, Carlson PJ, et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 2007; 9(6): 561–70 ArticlePubMedCAS Google Scholar
Yildiz A, Guleryuz S, Ankerst DP, et al. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 2008; 65(3): 255–63 ArticlePubMedCAS Google Scholar
Seelan RS, Khalyfa A, Lakshmanan J, et al. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience 2008; 151(4): 1184–97 ArticlePubMedCAS Google Scholar
Lenox RH, et al. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? J Clin Psychiatry 1996; 57Suppl. 13:23–31 PubMedCAS Google Scholar
Iwata S, Hewlett GH, Gnegy ME. Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. Synapse 1997; 26(3): 281–91 ArticlePubMedCAS Google Scholar
Iwata SI, Hewlett GH, Ferrell ST, et al. Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine. J Pharmacol Exp Ther 1997; 283(3): 1445–52 PubMedCAS Google Scholar
Johnson DN. Effect of diazepam on food consumption in rats. Psychopharmacology (Berl) 1978; 56(1): 111–2 ArticleCAS Google Scholar
Papp M, Willner P, Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 1991; 104(2): 255–9 ArticleCAS Google Scholar
Aujla H, Beninger RJ. Intra-accumbens protein kinase C inhibitor NPC 15437 blocks amphetamine-produced conditioned place preference in rats. Behav Brain Res 2003; 147(1–2): 41–8 ArticlePubMedCAS Google Scholar
Baum AE, Akula N, Cabanero M, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13(2): 197–207 ArticlePubMedCAS Google Scholar
Wellcome Trust Case Control Consortium. Genomewide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447(7145): 661–78 Article Google Scholar
Jordan VC. Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat 1994; 31(1): 41–52 ArticlePubMedCAS Google Scholar
Horgan K, Cooke E, Hallett MB, et al. Inhibition of protein kinase C mediated signal transduction by tamoxifen: importance for antitumour activity. Biochem Pharmacol 1986; 35(24): 4463–5 ArticlePubMedCAS Google Scholar
Couldwell WT, Weiss MH, DeGiorgio CM, et al. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 1993; 32(3): 485–9 ArticlePubMedCAS Google Scholar
Tang P, Roldan G, Brasher PM, et al. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma. J Neurooncol 2006; 78(3): 311–6 ArticlePubMedCAS Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994 Google Scholar
Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–35 ArticlePubMedCAS Google Scholar
Goldstein JA. Danazol and the rapid-cycling patient. J Clin Psychiatry 1986; 47(3): 153–4 PubMedCAS Google Scholar
Lopez M, Lelliott CJ, Tovar S, et al. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 2006; 55(5): 1327–36 ArticlePubMedCAS Google Scholar
Cathcart CK, Jones SE, Pumroy CS, et al. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 1993; 27(3): 277–81 ArticlePubMedCAS Google Scholar
Legha SS. Tamoxifen in the treatment of breast cancer. Ann Intern Med 1988; 109(3): 219–28 PubMedCAS Google Scholar
Costanzo ES, Lutgendorf SK, Mattes ML, et al. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 2007; 97(12): 1625–31 ArticlePubMedCAS Google Scholar
Gould TD, Quiroz JA, Singh J, et al. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 2004; 9(8): 734–55 ArticlePubMedCAS Google Scholar
Catapano L, Manji H. Kinases as drug targets in the treatment of bipolar disorder. Drug Development Today 2008; 13: 295–302 ArticleCAS Google Scholar
Podar K, Raab MS, Chauhan D, et al. The therapeutic role of targeting protein kinase C in solid and hematologic malignancies. Expert Opin Investig Drugs 2007; 16(10): 1693–707 ArticlePubMedCAS Google Scholar
Martinez A, Castro A, Medina M. Glycogen synthase kinase 3 (GSK-3) and its inhibitors. Hoboken (NJ): John Wiley & Sons, Inc., 2006 Book Google Scholar
Tohen M. Clinical trials in bipolar mania: implications in study design and drug development. Arch Gen Psychiatry 2008; 65(3): 252–3 ArticlePubMed Google Scholar